Biovie (BIVI) Times Interest Earned (2013 - 2026)
Biovie (BIVI) posted Times Interest Earned of -$14.72 for Q1 2026, up 69.28% sequentially from -$47.9 in Q4 2025, and up 37.8% YoY from -$10.68 in Q1 2025.
Biovie (BIVI) Times Interest Earned (2013 - 2026) Analysis & Trends
Biovie has reported Times Interest Earned for 12 years, with the latest figure at -$14.72 in Q1 2026.
- Quarterly Times Interest Earned rose 37.8% year-over-year to -$14.72 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$56.28 (up 62.96% YoY) and the FY2025 annual result came in at -$0.24, up 47.83% from the prior year.
- Times Interest Earned advanced to -$14.72 in Q1 2026 per BIVI's latest filing, from -$47.9 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$5.63 in Q2 2022 and troughed at -$732.91 in Q2 2025.
- A 5-year average of -$62.03 and a median of -$12.29 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned surged 96.79% in 2022, then plunged 6631.08% in 2025.
- Over 5 years, Times Interest Earned stood at -$10.45 in 2022, then fell by 2.41% to -$10.7 in 2023, then tumbled by 921.73% to -$109.34 in 2024, then surged by 56.19% to -$47.9 in 2025, then surged by 69.28% to -$14.72 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$14.72, -$47.9, and -$12.38 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Biovie | 14.17 Mn | 14.17 Mn | - | -1,437.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,437.77 |
| Mar 31, 2026 | -14.72 |
| Dec 31, 2025 | -47.90 |
| Sep 30, 2025 | -12.38 |
| Jun 30, 2025 | -732.91 |
| Mar 31, 2025 | -23.66 |
| Dec 31, 2024 | -109.34 |
| Sep 30, 2024 | -16.10 |
| Jun 30, 2024 | -10.89 |
| Mar 31, 2024 | -12.29 |
| Dec 31, 2023 | -10.70 |
| Sep 30, 2023 | -10.83 |
| Jun 30, 2023 | -9.98 |
| Mar 31, 2023 | -12.52 |
| Dec 31, 2022 | -10.45 |
| Sep 30, 2022 | -8.03 |
| Jun 30, 2022 | -5.63 |
| Mar 31, 2022 | -6.26 |
| Dec 31, 2021 | -21.07 |
| Sep 30, 2021 | -250.10 |